Information Library
Business transformation
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Shaping Clinical Transformation
November 18, 2009
A summary of key insights exchanged between pharma executives at the inaugural Quintiles Consulting Executive Vision Forum. -
CRO Partnerships 2010
April 12 - April 14, 2010
19th Annual Partnerships with CROs conference -
QUINTILES ANNOUNCES CLINICAL PHARMACOLOGY ALLIANCE WITH ASTRAZENECA
November 2, 2009 - Quintiles has entered into in an industry-leading clinical pharmacology alliance with AstraZeneca to deliver AstraZeneca’s clinical pharmacology studies across multiple therapy areas and around the globe. -
Enabling Transformation
September 30, 2009
Biovitrum found an ideal opportunity to transform itself into a fully integrated specialty pharmaceutical company from a biotech discovery and early clinical development company. -
Patient-centric Services Europe
September 24, 2009
What does the term HMS stand for and what exactly are patient-centric programs? Who benefits and how do successful programs look like? Germany and UK are used to demonstrate effectiveness of these programs. -
Tissue Biomarkers in Oncology Clinical Development: The Digital Advantage
September 15, 2009
The advantages of incorporating digital pathology into your oncology clinical development process. -
Innovex Success At PharmaField Awards Including New Hospital Rep of the Year
August 14, 2009
Competitions such as the one run by PharmaField help us to showcase our talent and demonstrate that we have many of the best and brightest in the business. -
Exceeding expectations
August 13, 2009
Discover how the scale of some marketing challenges stretches even the most powerful companies. -
The Future of Data Management
June 30, 2009
Paula Brown Stafford, MPH EVP, Integrated Clinical Services -
Should Venture Firms Bundle Their Biotech Portfolios?
June 29, 2009
Ron Wooten, president of NovaQuest, an investment and business-development unit of Quintiles Transnational Corp., a contract-research organization, thinks so.